1. Home
  2. UDR vs RGEN Comparison

UDR vs RGEN Comparison

Compare UDR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UDR Inc.

UDR

UDR Inc.

HOLD

Current Price

$36.22

Market Cap

13.2B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$176.75

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDR
RGEN
Founded
1972
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
UDR
RGEN
Price
$36.22
$176.75
Analyst Decision
Buy
Buy
Analyst Count
22
22
Target Price
$40.45
★ $197.95
AVG Volume (30 Days)
★ 3.7M
1.2M
Earning Date
11-02-2026
10-27-2026
Dividend Yield
★ 4.97%
N/A
EPS Growth
★ 334.62
286.96
EPS
★ 0.57
0.24
Revenue
★ $1,712,317,000.00
$141,236,000.00
Revenue This Year
N/A
$12.87
Revenue Next Year
$2.65
$29.67
P/E Ratio
★ $61.50
$750.67
Revenue Growth
2.42
★ 35.10
52 Week Low
$32.94
$100.99
52 Week High
$42.00
$198.87

Technical Indicators

Market Signals
Indicator
UDR
RGEN
Relative Strength Index (RSI) 67.80 49.30
Support Level $33.52 $158.62
Resistance Level $38.38 $188.73
Average True Range (ATR) 0.65 9.30
MACD 0.33 -0.36
Stochastic Oscillator 93.67 51.66

Price Performance

Historical Comparison
UDR
RGEN

About UDR UDR Inc.

UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: